1. Drug-sensitivity profile of clinical Mycobacterium tuberculosis isolates – a retrospective study from a chest-disease institute in India
- Author
-
Mridula Bose, M Isa, and Tapen Dam
- Subjects
Adult ,Male ,Microbiology (medical) ,Drug ,Ofloxacin ,medicine.medical_specialty ,Tuberculosis ,medicine.drug_class ,media_common.quotation_subject ,Antitubercular Agents ,India ,Microbial Sensitivity Tests ,Drug resistance ,Microbiology ,Mycobacterium tuberculosis ,Ciprofloxacin ,Internal medicine ,Drug Resistance, Bacterial ,Isoniazid ,medicine ,Humans ,Treatment Failure ,Tuberculosis, Pulmonary ,Aged ,Retrospective Studies ,media_common ,biology ,business.industry ,Sputum ,Retrospective cohort study ,General Medicine ,Middle Aged ,Quinolone ,medicine.disease ,biology.organism_classification ,Surgery ,Female ,Rifampin ,business ,medicine.drug - Abstract
Multi-drug-resistant tuberculosis (MDR-TB) is a major public-health problem, because treatment is complicated and patients remain infectious for months or years, despite receiving the best available therapy. To gain better understanding of MDR-TB, a retrospective study was initiated to determine the level of drug resistance among patients in a chest-disease institute in India. Two hundred and sixty-three isolates from treatment-failure pulmonary tuberculosis patients (20–70 years) were studied. Drug-sensitivity testing was performed by the modified-proportion method. First- and second-line drugs, along with two quinolone drugs (ofloxacin and ciprofloxacin), were tested. Patients included in this study did not improve with therapy; however, 151 isolates (57.5 %) were susceptible to all four first-line antituberculosis drugs. This study reports low resistance to fluoroquinolones among the strains present in these patients.
- Published
- 2005
- Full Text
- View/download PDF